Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 1 3Phase 4 2Phase NA 1Phase EARLY_PHASE1 1Phase 3 1

Status

Completed 8Terminated 3Withdrawn 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 2Sarcoma 1Head & Neck 1

Conditions

Glioma 2Brain Neoplasms 2Astrocytoma 2Oligodendroglioma 1Leukoplakia, Oral 1Gliosarcoma 1Glioblastoma 1

Interventions

Cyclophosphamide 98pembrolizumab 87Gemcitabine 81Carboplatin 63fludarabine 62Nivolumab 57Cisplatin 54Paclitaxel 51Radiotherapy 50Docetaxel 50Rituximab 46Dexamethasone 42Lenalidomide 41Ipilimumab 38Azacitidine 35Etoposide 34Cytarabine 34Temozolomide 32Bevacizumab 32Radiation 29venetoclax 28Bortezomib 27Magnetic Resonance Spectroscopy 26Irinotecan 26atezolizumab 25Pemetrexed 25Oxaliplatin 24Capecitabine 24fludarabine phosphate 23Filgrastim 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Terminated × Aminolevulinic Acid × Clear all
NCT01148966 2017-02-15

Aminolevulinic Acid During Surgery in Treating Patients With Malignant Brain Tumors

University of Washington

Phase 1 Terminated
6 enrolled
CNSSarcoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma, Gliosarcoma

NCT01502605 2017-01-05

Phase I Study of Orally Administered Aminolevulinic Acid for Resection of Malignant Astrocytomas

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 1 Terminated
6 enrolled
CNS

Astrocytoma, Brain Neoplasms, Glioma

NCT00571558 2014-10-09

Photodynamic Therapy Using Aminolevulinic Acid in Treating Patients With Oral Leukoplakia

National Cancer Institute (NCI)

Phase 1 Terminated
15 enrolled
Head & Neck

Leukoplakia, Oral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡